Recent Patents Involving Virus Nucleotide Sequences; Host Defense, RNA Silencing and Expression Vector Strategies
Abstract:Improved knowledge of the molecular biology of viruses, including recent gains in virus sequence data analysis, has greatly contributed to recent innovations in medical diagnostics, therapeutics, drug development and other related areas. Virus sequences have been used for the development of vaccines and antiviral agents to block the spread of viral infections, as well as to target and battle chronic diseases such as cancer. Virus sequences are now routinely employed in a wide array of RNA silencing technologies. Viruses can also be engineered into expression vectors which in turn can be used as protein production platforms as well as delivery vehicles for gene therapies. This review article outlines a number of patents that have been recently issued with respect to virus sequence data and describes some of their biotechnological applications.
Keywords: Expression Vector Strategies; Host Defense; Kill Cancer Cells; Oncolytic virus; Prodrugs of HIV; RNA Silencing; Sequences; Virus Nucleotide; Viruses to Treat Diseases; antiviral agents; cytokines; gene silencing; hepatitis C; neoplasms; nucleoside phosphates; vaccine; virus expression vector
Document Type: Research Article
Publication date: December 1, 2011
- Recent Patents on DNA and Gene Sequences publishes review articles by experts on recent patents on DNA and gene sequences. A selection of important and recent patents in the field is also included in the journal. The journal is essential reading for all researchers involved in applied molecular biology.